Improving Bowel Preparation for the Colon Capsule
NCT01655095 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2015-12-03
Summary
Colon capsule endoscopy is a technology that has been developed as a noninvasive method of examining the large bowel. The biggest limitation to its use has been finding a bowel preparation that will both clean the colon adequately for good visualization of the mucosa and also help propel the capsule through the colon. Most studies have been conducted in Europe using bowel preparation medications that are not approved for use in North America.
The purpose of this study is to compare a combination of polyethylene glycol (PEG) and prucalopride to Picosalax and prucalopride to determine which regime will give a better colon cleanse for the colon capsule. Both PEG and Picosalax are bowel preparations that are used routinely for colonoscopy in Canada. Prucalopride is a new medication recently approved for use in Canada which improves intestinal motility and should help with colon capsule transit.
Patients who are being referred for colonoscopy will be enrolled in the study and randomized to one of the bowel preparation regimes. They will undergo a split-dose bowel preparation with either PEG or Picosalax, which is routine for colonoscopy. As part of the standard bowel preparation, patients randomized to the Picosalax group will take dulcolax three nights before the test and then again two nights before the test. The evening before the test patients will take either PEG 2L or one sachet of Picosalax. The following morning they will take another dose of either PEG (2 Liter container) or one sachet of Picosalax. They will then ingest the colon capsule and a dose of Prucalopride that morning. After 7 hours they will return to the endoscopy unit where they will undergo a colonoscopy, which is the standard of care for examination of the colon.
The images from the colon capsule will be reviewed and the quality of bowel preparation will be graded using a previously validated scale. It is hypothesized that the Picosalax and prucalopride regime will give a better cleanse for the colon than PEG and prucalopride as there will be less turbid fluid in the colon and allow for a better view of the mucosa. Polyp detection and abnormalities of the mucosa detected with the colon capsule will also be compared to polyps and abnormalities detected at the time of colonoscopy.
Conditions
- Quality of Bowel Preparation for the Colon Capsule
- Colon Capsule Completion Rates
- Colon Capsule Polyp Detection
Interventions
- DRUG
-
PEG
PEG 2L at 1800hrs the night before the test and 2L at 0500hrs the morning of the test.
- DRUG
-
Prucalopride
Prucalopride 2mg will be administered at 0800hrs on the day of the test, at the same time the colon capsule is administered. Two hours later the position of the colon capsule will be assess with a Realtime Viewer. If the capsule has not reached the cecum a second dose of Prucalopride 2mg will be administered at that time.
- DRUG
-
Picosalax
One sachet at 1800hrs the night before the test One sachet at 0500hrs the day of the test
- DRUG
-
Bisacodyl
Bisacodyl 10mg in the evening three nights before the procedure and 10mg again two nights before the procedure.
- PROCEDURE
-
Colon capsule
The colon capsule will be ingested at 0800hrs the day of the test. Seven hours will be allowed for the capsule to clear the bowel. The images will be reviewed by two endoscopists with experience reading video capsule endoscopy.
- PROCEDURE
-
Colonoscopy
At 1500hrs on the day of the test all individuals will return to the endoscopy unit for a colonoscopy.
Sponsors & Collaborators
-
Hotel Dieu Hospital (Gastrointestinal Diseases Research Unit)
collaborator UNKNOWN -
Queen's University
lead OTHER
Principal Investigators
-
Lawrence Hookey · Queens University
-
Darlene Brady · Queens University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- Canada
Study Locations
More Related Trials
-
Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy
NCT01533090 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Polyethylene Glycol Compared With Sodium Picosulphate for Bowel Preparation Before Colonoscopy
NCT01093274 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy
NCT03410524 ·Status: COMPLETED ·Phase: PHASE3
-
Colonoscopy Preparation Optimization for INpatients- COIN Study
NCT01627171 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy
NCT01610856 ·Status: COMPLETED ·Phase: NA
-
Bowel Cleansing for Colonoscopy: Comparison Between a Same Day Low-Volume Preparation and a Conventional 4L Split One
NCT01685853 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy
NCT02119000 ·Status: TERMINATED ·Phase: PHASE4
-
Comparing Bowel Preparation Regimens for Flexible Sigmoidoscopy
NCT01554111 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy
NCT00410215 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy
NCT01356407 ·Status: COMPLETED ·Phase: PHASE3
-
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
NCT01518790 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy
NCT01928862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Different Bowel Preparations for Colonoscopy In Children
NCT01711437 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Tailored Bowel Preparation Strategy: A Randomized Controlled Study
NCT03765216 ·Status: UNKNOWN ·Phase: NA
-
Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy
NCT01929590 ·Status: COMPLETED ·Phase: PHASE3
-
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
NCT02956057 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population
NCT00906217 ·Status: COMPLETED
-
Preparation Prior to Colonoscopy in Children
NCT02009202 ·Status: COMPLETED ·Phase: NA
-
PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy
NCT01531140 ·Status: COMPLETED ·Phase: PHASE4
-
Low Volume Colon Preparation for IBD
NCT02248337 ·Status: COMPLETED ·Phase: PHASE4
-
Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults
NCT05726344 ·Status: COMPLETED ·Phase: NA
-
Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose
NCT01415687 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation
NCT01513096 ·Status: COMPLETED ·Phase: PHASE3
-
Prucalopride Prior to Small Bowel Capsule Endoscopy
NCT02806206 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
NCT01685970 ·Status: UNKNOWN ·Phase: PHASE3